{
    "SPADE_UN_21204": {
        "Sequence Information": {
            "Peptide Name": "Cycl-Arenicin-1",
            "Sequence": "RWCVYAYVRVRGVLVRYRRCW",
            "Sequence Length": 21,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "Q5SC60",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/Q5SC60",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization.",
                    "Pubmed ID": "31234579",
                    "Reference": "Mar Drugs. 2019;17:",
                    "Author": "Orlov DS, Shamova OV, Eliseev IE, Zharkova MS, Chakchir OB, Antcheva N, Zachariev S, Panteleev PV, Kokryakov VN, Ovchinnikova TV, Tossi A",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/31234579"
                }
            ],
            "Mass": 2760.3,
            "PI": 10.85,
            "Net Charge": 6,
            "Hydrophobicity": -0.07,
            "Frequent Amino Acids": "RVY",
            "Absent Amino Acids": "DEFHIKMNOPQSTU",
            "Basic Residues": 6,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 9,
            "Polar Residues": 12,
            "Positive Residues": 6,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_21204",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_11684",
                    "Similarity": 1.0,
                    "Sequence": "RWCVYARVRGVRYRRCW"
                },
                {
                    "SPADE_ID": "SPADE_UN_19236",
                    "Similarity": 1.0,
                    "Sequence": "RWCVYARVRGVRYRRCW"
                },
                {
                    "SPADE_ID": "SPADE_UN_21204",
                    "Similarity": 1.0,
                    "Sequence": "RWCVYAYVRVRGVLVRYRRCW"
                }
            ],
            "Hemolytic Activity": "Human erythrocytes:15% Hemolysis=14 µM,Human erythrocytes:50% Hemolysis=65.5 µM",
            "Target Organism": "Escherichia coli ML-35p(MIC=1-2µM),Escherichia coli ATCC 25922(MIC=2µM),Escherichia coli M15(MIC=2µM),Pseudomonas aeruginosa ATCC 27853(MIC=1µM),Listeria monocytogenes EGD(MIC=2µM),Staphylococcus aureus 710A(MIC=2µM),Staphylococcus aureus ATCC 25923(MIC=2µM),Staphylococcus aureus ATCC 33591(MIC=4µM),Staphylococcus aureus(MIC=4µM),Staphylococcus intermedius(MIC=4µM),Pseudomonas aeruginosa(MIC=2µM),Acinetobacter baumannii(MIC=4µM),Human myelogenous leukemia K562(IC50=16.2µM)"
        }
    }
}